Why is Christian Science in our name? Our name is about honesty. The Monitor is owned by The First Church of Christ, Scientist, and we’ve always been transparent about that. The church publishes the ...

Mr. Lopez is a writer for the editorial board. See more of our coverage in your search results.Encuentra más de nuestra cobertura en los resultados de búsqueda. Add The New York Times on GoogleAgrega ...

The chip design firm says Meta, OpenAI, Cerebras, and Cloudflare are among the first customers of its new artificial intelligence hardware. “Let me be clear: We are now in a new business for ARM, and ...

Elon Musk, famously a man with big ideas, is building a semiconductor plant vast enough to power those ambitions. Musk on Saturday announced what he calls the "Terafab," a semiconductor manufacturing ...

With a third of the global supply offline because of the war in Iran, gas companies are scrambling to assure critical A.I. chip makers there will be no disruptions. Air Liquide supplies helium and ...

This story appears in the Good Food Guide to chips Victoria collection. See all stories. A hot chip taste test is exactly what it sounds like. You order some chips, try a few for research purposes, ...

A blue-chip stock is a stock that comes from a well-known, established company. Blue-chip stocks have a strong history of performance and often pay dividends. Many, or all, of the products featured on ...

Replimune Group Inc (NASDAQ:REPL) surged 60% in premarket trading after the U.S. Food and Drug Administration (FDA) accepted the company’s resubmission of its Biologics License Application (BLA) for ...

TSMC leads with 70% of the Q3 2025 semiconductor foundry revenue, 10x more than competitors. Samsung, SMIC, and UMC hold minor shares, signaling TSMC's strong market grip. The U.S. government took a ...

Arm Holdings stock tumbled after the company unveiled its ambitious plan to enter the market for data-center chips. But shares later reversed course and headed for their best day in nearly a year.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...